Amgen Ventures focuses on early-stage companies developing human therapeutics in oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, and cardiovascular areas. The firm primarily invests in Series A and B rounds, targeting companies in the United States and Europe. Their investment strategy aligns with Amgen's core mission as a global biopharmaceutical innovator.
Notable portfolio companies include Alector, BeiGene, and Generate Biomedicines. Amgen Ventures leverages its parent company's expertise in biotechnology to provide strategic support and resources to its portfolio companies. This unique positioning allows them to offer valuable insights and potential collaboration opportunities within the broader Amgen ecosystem, enhancing the growth potential of their investments.
Amgen Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
